| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 06/15/2011 | CN101104598B Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/09/2011 | WO2011009826A3 Novel chalcone derivatives with cytotoxic activity |
| 06/09/2011 | US20110136796 IDO Inhibitors |
| 06/08/2011 | EP2328877A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 06/08/2011 | CN1882524B 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 06/08/2011 | CN102086189A Method for preparing compound |
| 06/08/2011 | CN102086184A 5-fluorine-substituted 4-hydroxyl-3,4,5,6-tetrahydro-2H-pyrane-2-ketone compound and preparation method thereof |
| 06/07/2011 | US7955664 Chroman compounds |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/02/2011 | US20110130575 Synthesis of clay-templated subnano-sized zero valent iron (zvi) particles, clays containing same, and use of both in contaminant treatments |
| 06/01/2011 | EP2326635A1 Novel substituted sulfamide derivatives |
| 05/31/2011 | US7951433 Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device |
| 05/31/2011 | US7951432 Five-ring liquid crystal compound having cyclohexane ring, liquid crystal composition, and liquid crystal display device |
| 05/26/2011 | WO2011061277A1 Amino aryl acetamides and their use in the treatment of malaria |
| 05/26/2011 | US20110124679 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| 05/26/2011 | US20110124648 Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/25/2011 | EP2049623B1 Use of a product comprising glycerol formal monoesters of fatty acids as a biofuel |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102070600A Method for preparing compound |
| 05/25/2011 | CN102070599A Norsesquiterpenoid peralcohol and preparation method and application thereof |
| 05/25/2011 | CN102070598A Norsesquiterpenoid peroxides and preparation method thereof and antitumor use thereof |
| 05/25/2011 | CN102069010A Montmorillonite catalyst used in preparation of cyclic carbonate |
| 05/24/2011 | US7947851 1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | CA2464807C Phenyl-propargylether derivatives |
| 05/19/2011 | WO2011059731A1 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/19/2011 | US20110118476 Process for Preparing Chiral Compounds |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118330 Hiv protease inhibitors and methods for using |
| 05/18/2011 | EP2322518A1 Method of manufacture of 1,3-dioxolane and 1,3-oxathiolane nucleosides |
| 05/18/2011 | EP2321294A2 Process for preparing a mixture of lactide derivatives |
| 05/18/2011 | EP2321259A2 New compounds for the treatment of cancer |
| 05/18/2011 | EP1698618B1 Benzamide derivative |
| 05/18/2011 | EP1318140B1 Novel amide derivatives and medicinal use thereof |
| 05/18/2011 | CN102066305A Process for producing alpha-hydroxy acid |
| 05/12/2011 | US20110112313 Preparation of fluorinated 1,3-benzodioxanes |
| 05/12/2011 | US20110112309 Preparation process useful in synthesis of atorvastatin |
| 05/12/2011 | US20110112065 Modulators of dopamine neurotransmission |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP1357119B1 Process for producing lactide and process for producing polylactic acid starting with fermented lactic acid |
| 05/11/2011 | CN102056882A Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition and liquid crystal display element |
| 05/11/2011 | CN102056881A Tetracyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display element |
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/05/2011 | WO2011051960A2 Process for the preparation of rapamycin derivatives |
| 05/05/2011 | WO2005060456A9 Method for treating adamts-5-associate disease |
| 05/05/2011 | US20110105462 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105461 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | US20110102528 Composition, resist film, pattern forming method, and inkjet recording method |
| 05/05/2011 | DE10229476B4 Flüssigkristalline Verbindungen, sie enthaltende flüssigkristalline Medien und ihre Verwendung für elektrooptische Zwecke Liquid-crystalline compounds, compositions containing them and their use in liquid-crystalline media for electro-optical purposes |
| 05/04/2011 | EP2315759A1 Method for storing and transporting cyclic diesters |
| 05/04/2011 | CN102040583A Method for preparing high-purity liquid-phase chromatographic grade 1,4-dioxane |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102040521A Polymerizable compound |
| 05/03/2011 | US7935835 Substituted cycloalkene derivative |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 04/28/2011 | WO2011048425A1 Continuous process for the production of beta-keto esters by claisen condensation |
| 04/28/2011 | WO2011006566A3 Monomethoxy-hydroxy-benzylmalonate diesters |
| 04/28/2011 | US20110098438 Production Process of Alpha-Hydroxy Acids |
| 04/28/2011 | CA2780027A1 Continuous process for the production of beta-keto esters by claisen condensation |
| 04/27/2011 | EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 04/27/2011 | EP2313389A1 Method of obtaining lactide |
| 04/27/2011 | CN102036976A Modulators of dopamine neurotransmission |
| 04/27/2011 | CN102031164A Carbinol gasoline additive and preparation method and application thereof |
| 04/27/2011 | CN102030690A Di-sulfoxide ligands with axial chirality and synthesis method thereof |
| 04/27/2011 | CN101092415B Compound of new benzo heterocycle categories, preparation method and application |
| 04/20/2011 | EP2310372A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/20/2011 | CN102020628A Improved method of preparation process of polylactic acid midbody lactide |
| 04/20/2011 | CN102020627A Method for preparing trimethylolpropane ketal acrylate |
| 04/19/2011 | US7928251 Process for preparing tetramethyl glycolide |
| 04/19/2011 | CA2490205C Process for the preparation of dioxane acetic acid esters |
| 04/14/2011 | US20110087013 Friedel-Crafts acylation for the synthesis of aryl- and heteroaryl-(3-ethyl-4-nitrophenyl)-methanones |
| 04/13/2011 | EP2307017A1 Compounds which can be used for the treatment of cancers |
| 04/13/2011 | CN102015674A Modulators of dopamine neurotransmission |
| 04/13/2011 | CN102010281A Preparation method of alpha-acyloxy ether |
| 04/13/2011 | CN101421230B Novel phenyl-propargylether derivatives |
| 04/12/2011 | US7923446 Biaryl sulfonamides and methods for using same |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/07/2011 | WO2011038857A2 Alkoxylated glycerol acetals and their derivatives |
| 04/07/2011 | WO2010091109A3 Tuned synthetic dendrimer calibrants for mass spectrometry |
| 04/07/2011 | WO2010008776A3 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 04/07/2011 | US20110082109 Novel acyl guanidine derivatives |
| 04/06/2011 | EP2305662A1 Alkoxylated glycerol acetals and their derivatives |
| 04/06/2011 | EP2305627A1 Tetracyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display element |
| 04/06/2011 | EP1303479B1 7-, 8- and 9-substituted tetracycline compounds |
| 04/05/2011 | US7919529 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 04/05/2011 | US7919523 Inhibitors of aspartyl protease |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/31/2011 | WO2011038337A1 Ketal lactones and stereospecific adducts of oxocarboxylic ketals with trimethylol compounds, polymers containing the same, methods of manufacture, and uses thereof |
| 03/31/2011 | WO2010117435A3 No-carrier-added nucleophilic [f-18] fluorination of aromatic compounds |
| 03/31/2011 | WO2010085377A3 Hydroxamic acid derivatives |
| 03/31/2011 | US20110077417 Intermediates for Hydroxylated Contrast Enhancement Agents |
| 03/31/2011 | US20110077396 Intermediates for hydroxylated contrast enhancement agents |
| 03/31/2011 | CA2774233A1 Ketal lactones and stereospecific adducts of oxocarboxylic ketals with trimethylol compounds, polymers containing the same, methods of manufacture, and uses thereof |
| 03/29/2011 | US7915431 Process for production of flake-like dried 2-(5-ethyl-5-hydroxymethyl-1,3-dioxan-2-yl)-2-methylpropan-1-ol |
| 03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
| 03/29/2011 | CA2460640C Diaryl ether derivatives, salts thereof and immunosuppressive agents using the same |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011033937A1 Liquid crystalline compound, liquid crystal composition, and liquid crystal display element |